Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 681 for “"PD-L1"”.

  1. PD-1/PD-L1 immunotherapy blockade in solid tumors: role of PD-1/PD-L1 in cancer disease progression

    … concept behind cancer and focuses on the use of PD-1 in tumors as a way of immune evasion as well as the use of PD-1/PD-L1 blockade as an innovative target for immunotherapy. Cancer arises from mutagenic events resulting in the presence of abnormal cells and uncontrollable cell proliferation. It …

    bu Repository record for PD-1/PD-L1 immunotherapy blockade in solid tumors: role of PD-1/PD-L1 in cancer disease progression (opens in a new tab)

  2. PD-L1 Nano-Eraser: A Novel Intracellular PD-L1 Degradation Approach and Its Application in Cancer and Alzheimer’s Disease Therapy

    … application of anti-Programmed Death Ligand 1 (PD-L1) antibody (aPDL1) in cancer treatment and Alzheimer’s disease therapy by leveraging the Trim-Away pathway. aPDL1-based Trim-Away involves tagging target PD-L1 with TRIM21, and followed by proteasome-mediated degradation of PD-L1, leading to …

    south-carolina Repository record for PD-L1 Nano-Eraser: A Novel Intracellular PD-L1 Degradation Approach and Its Application in Cancer and Alzheimer’s Disease Therapy (opens in a new tab)

  3. PD-L1 expression by tumor macrophages: regulation and signaling

    To view the abstract, please see the full text of the document.

    colostate Repository record for PD-L1 expression by tumor macrophages: regulation and signaling (opens in a new tab)

  4. Regulation of the immune checkpoint PD-L1 by microRNAs

    … responses and inflammation. The expression of PD-L1 protein is found on some normal and cancer cells and contributes to suppression of T cell activity by acting as a brake on the immune response. Previously, it has been shown that posttranscriptional mechanisms regulate PD-L1 levels in cancer, …

    whiterose Download PDF for Regulation of the immune checkpoint PD-L1 by microRNAs (opens in a new tab)

  5. Tumour copper levels regulate PD-L1 driven immune evasion

    … over-expression of Programmed Death Ligand 1 (PD-L1). The immune checkpoint protein Programmed Death receptor 1 (PD-1) expressed by lymphocytes negatively regulates T-cells effector functions against target cells, including tumour cells. Several therapeutic monoclonal antibodies targeting …

    unsw Repository record for Tumour copper levels regulate PD-L1 driven immune evasion (opens in a new tab)

  6. A THERANOSTIC APPROACH TOWARDS PROGRAMMED DEATH-LIGAND 1 (PD-L1)

    … and eliminate cancer. Programmed death-ligand 1(PD-L1) is a crucial immune checkpoint marker that inhibits anti-tumor response by engaging with its ligand, PD-1 on cytotoxic T cells. Targeting PD-1/PD-L1 axis remains avidly explored avenue clinically, however, a substantial subset of patients …

    jhu Repository record for A THERANOSTIC APPROACH TOWARDS PROGRAMMED DEATH-LIGAND 1 (PD-L1) (opens in a new tab) Embargoed until 2028-05-01

  7. Lipid-based microbubbles for enhanced delivery of anti PD-l1

    … conjugating immunotherapeutic drugs, i.e. anti PD-L1, onto microbubbles via chemical conjugation or physical methods. However, clinical translation requires an accurate characterisation method for antibody loading, as well as the establishment of point-of-care manufacturing processes for …

    oxford Restricted access

  8. Tumor Intrinsic Consequences of Acquired Resistance to PD-L1 Inhibition

    Programmed death ligand 1 (PD-L1) expressed on tumor cells can bind to its receptor PD-1 on T cells to effectively block tumor suppressing immunity. Immune checkpoint inhibitors (ICIs) include drugs that target PD-L1, several of which are clinically approved to treat late- and early-stage cancers. …

    buffalo Repository record for Tumor Intrinsic Consequences of Acquired Resistance to PD-L1 Inhibition (opens in a new tab)

  9. Entwicklung von niedermolekularen PD-L1- Radioliganden für die PET-Bildgebung

    Der Programmed Death-Ligand 1 (PD-L1) wird von verschiedenen Tumorentitäten überexprimiert und hemmt durch die Bindung an das auf T-Zellen vorkommende Programmed Cell Death Protein (PD-1) die Immunantwort. Immuncheckpoint-Inhibitoren sind in der Lage, diese Blockade aufzubrechen und die …

    qucosa-diss

  10. THE ROLE OF IMMUNE CHECKPOINT PD-L1 IN HOMEOSTASIS AND INFLAMMATION

    … immune checkpoint, programmed death ligand 1 (PD-L1), in arthritis through the development of an immune checkpoint inhibitor-induced inflammatory arthritis mouse model (ICI-IA) by blocking PD-L1 during collagen induced arthritis (CIA). The joints of ICI-IA mice showed severe arthritis with …

    jhu Repository record for THE ROLE OF IMMUNE CHECKPOINT PD-L1 IN HOMEOSTASIS AND INFLAMMATION (opens in a new tab)

  11. Development of Gold Nanoparticles for Targeting PD-L1-Presenting Breast Cancers

    … programmed cell death protein ligand 1 (PD-L1) presenting cancer cells with gold nanoparticles (AuNP). Initially, small molecules, described as antagonists for the PD-1/PD-L1 interaction, were considered as promising targeting agents for the gold platform. The competitive binding profiles …

    uvic Repository record for Development of Gold Nanoparticles for Targeting PD-L1-Presenting Breast Cancers (opens in a new tab)

  12. Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries

    … is by expressing programmed death ligand 1 (PD-L1). PD-L1 binds to its receptor programmed death 1 (PD1) on T cells, inhibiting T cell responsiveness to antigenic stimuli. Blockade of the PD1/PD-L1 pathway removes this negative signal and restores anti-tumour immunity. While this blockade of …

    uvic Repository record for Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries (opens in a new tab)

  13. Parp Inhibitor Upregulates Pd-L1 Expression and Enhances Cancer-Associated Immunosuppression

    … for therapeutic antibodies that block CTLA4, PD-1 and PD-L1, immune checkpoints have emerged as new targets in cancer therapy. In addition, there is accumulating evidence highlighting the role of cancer-associated immunity in patient response to cytotoxic anticancer agents. Inhibitors of poly …

    uthsc Repository record for Parp Inhibitor Upregulates Pd-L1 Expression and Enhances Cancer-Associated Immunosuppression (opens in a new tab)

  14. Expression von PD-L1 und PD-1 im nicht-kleinzelligen Lungenkarzinom

    … beschäftigt sich mit der Expression der Proteine PD-L1 (B7-H1,<br>CD274) und PD-1 (CD279) auf Tumorzellen und TIL des NSCLC. Tumorseitig soll PD-L1 den auf<br>infiltrierenden Lymphozyten exprimierten Rezeptor PD-1 inhibieren und dadurch zu einer Anergie<br>des Immunsystems und in Folge dessen zu …

    freiburg-diss Repository record for Expression von PD-L1 und PD-1 im nicht-kleinzelligen Lungenkarzinom (opens in a new tab)

  15. Novel imaging technique to determine PD-L1 expression in breast cancer

    … triple negative breast cancer when treated with PD-L1 inhibitor pembrolizumab in the neoadjuvant and adjuvant phase of treatment. However, this result was independent of PD-L1 expression of the tumor as measured by immunohistochemistry (IHC). Studies also have found that IHC measurement of PD-L1 …

    bu Repository record for Novel imaging technique to determine PD-L1 expression in breast cancer (opens in a new tab)

  16. Epigenetic and Mechanotransducive Regulation of PD-L1 Expression in Breast Cancer Cells

    … TNBC patients.9,10 programmed death-ligand 1 (PD-L1) is an important immune checkpoint which overexpressed in TNBC.11 Here, epigenetic and mechanotransducive regulation of PD-L1 was examined in this study. We showed that in MDA-MB-231 cells, slicing and inhibition of MLL downregulate PD-L1 …

    jhu Repository record for Epigenetic and Mechanotransducive Regulation of PD-L1 Expression in Breast Cancer Cells (opens in a new tab)

  17. Characterizing PD-L1-Targeting Extracellular Vesicles Produced by Oncolytic Vaccinia Virus Infection

    … molecules. The programmed cell death ligand 1 (PD-L1) plays a major role in this immunosuppression, and its expression is often up regulated as a result of innate and adaptive resistance mechanisms. Recent studies have discovered that the expression of PD-L1 can also extend to the nanoparticles …

    ottawa-retro Repository record for Characterizing PD-L1-Targeting Extracellular Vesicles Produced by Oncolytic Vaccinia Virus Infection (opens in a new tab)

  18. Μελέτη της έκφρασης των PD-1/PD-L1 σε κακοήθη αιματολογικά νοσήματα

    … την πρώτη ύφεση της νόσου. Η αλληλεπίδραση των PD-1/PD-L1 συγκαταλέγεται στους πιθανούς τρόπους διαφυγής των νεοπλασματικών κυττάρων από την ανοσοεπιτήρηση. Η δυσλειτουργία των Τ λεμφοκυττάρων οφείλεται στη δράση του υποδοχέα PD-1 (Programmed Death-1), ο οποίος επάγεται από τον συνδέτη PD-L1 …

    athens Repository record for Μελέτη της έκφρασης των PD-1/PD-L1 σε κακοήθη αιματολογικά νοσήματα (opens in a new tab)

Page 1 of 35